AKLI Akili Inc

USD 0.41 -0.01 -2.380952
Icon

Akili Inc (AKLI) Stock Analysis and Price Targets

COMMON STOCK | Health Information Services | NSD
stockTargetAdvisor

N/A

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Slightly Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

Strong Buy

Average User
Rating

USD 0.41

-0.01 (-2.38)%

USD 0.03B

0.10M

N/A

USD 6.00 (+1363.41%)

Icon

AKLI

Akili Inc (USD)
COMMON STOCK | NSD
USD 0.41
0.00 0
Take a Tour
stockTargetAdvisor

N/A

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Slightly Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

Strong Buy

Average User
Rating

USD 0.03B

USD 6.00 (+1363.41%)

USD 0.41

Akili Inc (AKLI) Stock Forecast

N/A

Based on the Akili Inc stock forecast from 0 analysts, the average analyst target price for Akili Inc is not available over the next 12 months. Akili Inc’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of Akili Inc is Slightly Bearish, which is based on 3 positive signals and 5 negative signals. At the last closing, Akili Inc’s stock price was USD 0.41. Akili Inc’s stock price has changed by -5.11% over the past week, +71.55% over the past month and -68.70% over the last year.

No recent analyst target price found for Akili Inc
No recent average analyst rating found for Akili Inc

Company Overview Akili Inc

Akili, Inc., a digital medicine company, develops cognitive treatments through game-changing technologies. The company provides EndeavorRx, a computer-based testing for cognitive dysfunction across several neurology and psychiatry indications, including attention-deficit hyperact...Read More

125 Broad Street, Boston, MA, United States, 02110

68

December

USD

USA

Adjusted Closing Price for Akili Inc (AKLI)

Loading...

Unadjusted Closing Price for Akili Inc (AKLI)

Loading...

Share Trading Volume for Akili Inc Shares

Loading...

Compare Performance of Akili Inc Shares

Symbol Capital Gain Dividend Return Total Return
Loading...
Loading...

Technical Indicators for AKLI

Assets

Top Holdings

Top Sectors

Top Regions

Stocks Similar To Akili Inc (Sector: Health Information Services )

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
GEHC
GE HealthCare Technologies Inc.. -1.29 (-1.60%) USD37.23B 23.71 13.30

ETFs Containing AKLI

Symbol Name AKLI's Weight Expense Ratio Price(Change) Market Cap
no data

Frequently Asked Questions About Akili Inc (AKLI) Stock

Stock Target Advisor's fundamental analysis for Akili Inc's stock is Slightly Bearish.

Unfortunately we do not have enough data on AKLI's stock to indicate if its a good dividend stock.

Unfortunately we do not have enough data on AKLI's stock to indicate what its average analyst target is.

AKLI stock's Price/Earning ratio is 21.50. Our analysis grades AKLI stock's Price / Earning ratio at C-. This means that AKLI stock's Price/Earning ratio is above 29% of the stocks in the Health Information Services sector in the NSD exchange. Based on this AKLI may be undervalued for its sector.

The last closing price of AKLI's stock was USD 0.41.

The most recent market capitalization for AKLI is USD 0.03B.

Unfortunately we do not have enough analyst data on AKLI's stock to indicate whether its price will go up or not.

We can't find any ETFs which contains Akili Inc's stock.

As per our most recent records Akili Inc has 68 Employees.

Akili Inc's registered address is 125 Broad Street, Boston, MA, United States, 02110. You can get more information about it from Akili Inc's website at https://www.akiliinteractive.com.
Heading 1 Heading 2 Heading 3 Heading 4 Heading 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Loading...